Saccharomyces cerevisiae Genetics Predicts Candidate Therapeutic Genetic Interactions at the Mammalian Replication Fork

The concept of synthetic lethality has gained popularity as a rational guide for predicting chemotherapeutic targets based on negative genetic interactions between tumor-specific somatic mutations and a second-site target gene. One hallmark of most cancers that can be exploited by chemotherapies is chromosome instability (CIN). Because chromosome replication, maintenance, and segregation represent conserved and cell-essential processes, they can be modeled effectively in simpler eukaryotes such as Saccharomyces cerevisiae. Here we analyze and extend genetic networks of CIN cancer gene orthologs in yeast, focusing on essential genes. This identifies hub genes and processes that are candidate targets for synthetic lethal killing of cancer cells with defined somatic mutations. One hub process in these networks is DNA replication. A nonessential, fork-associated scaffold, CTF4, is among the most highly connected genes. As Ctf4 lacks enzymatic activity, potentially limiting its development as a therapeutic target, we exploited its function as a physical interaction hub to rationally predict synthetic lethal interactions between essential Ctf4-binding proteins and CIN cancer gene orthologs. We then validated a subset of predicted genetic interactions in a human colorectal cancer cell line, showing that siRNA-mediated knockdown of MRE11A sensitizes cells to depletion of various replication fork-associated proteins. Overall, this work describes methods to identify, predict, and validate in cancer cells candidate therapeutic targets for tumors with known somatic mutations in CIN genes using data from yeast. We affirm not only replication stress but also the targeting of DNA replication fork proteins themselves as potential targets for anticancer therapeutic development.

[1]  P. Hieter,et al.  An Evolutionarily Conserved Synthetic Lethal Interaction Network Identifies FEN1 as a Broad-Spectrum Target for Anticancer Therapeutic Development , 2013, PLoS genetics.

[2]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[3]  Grant W. Brown,et al.  Dissecting DNA damage response pathways by analyzing protein localization and abundance changes during DNA replication stress , 2012, Nature Cell Biology.

[4]  Arul M Chinnaiyan,et al.  PARP-1 inhibition as a targeted strategy to treat Ewing's sarcoma. , 2012, Cancer research.

[5]  S. Ramaswamy,et al.  Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.

[6]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[7]  P. Hieter,et al.  Synthetic Lethality of Cohesins with PARPs and Replication Fork Mediators , 2012, PLoS genetics.

[8]  David Pellman,et al.  Causes and consequences of aneuploidy in cancer , 2012, Nature Reviews Genetics.

[9]  P. Hieter,et al.  R-loop-mediated genome instability in mRNA cleavage and polyadenylation mutants. , 2012, Genes & development.

[10]  F. Spencer,et al.  Mutability and mutational spectrum of chromosome transmission fidelity genes , 2011, Chromosoma.

[11]  L. Loeb,et al.  Human cancers express mutator phenotypes: origin, consequences and targeting , 2011, Nature Reviews Cancer.

[12]  S. Moreno,et al.  Lsm1 promotes genomic stability by controlling histone mRNA decay , 2011, The EMBO journal.

[13]  Zoltan Szallasi,et al.  Paradoxical relationship between chromosomal instability and survival outcome in cancer. , 2011, Cancer research.

[14]  Frederick S. Vizeacoumar,et al.  Systematic exploration of essential yeast gene function with temperature-sensitive mutants , 2011, Nature Biotechnology.

[15]  Zhijian Li,et al.  The Complete Spectrum of Yeast Chromosome Instability Genes Identifies Candidate CIN Cancer Genes and Functional Roles for ASTRA Complex Components , 2011, PLoS genetics.

[16]  S. Gruber,et al.  MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers. , 2011, Cancer research.

[17]  Alan Ashworth,et al.  Searching for synthetic lethality in cancer. , 2011, Current opinion in genetics & development.

[18]  C. Ponting,et al.  Identification of the MMS22L-TONSL complex that promotes homologous recombination. , 2010, Molecular cell.

[19]  Grant W. Brown,et al.  The MMS22L-TONSL complex mediates recovery from replication stress and homologous recombination. , 2010, Molecular cell.

[20]  C. Obuse,et al.  Cul8/Rtt101 Forms a Variety of Protein Complexes That Regulate DNA Damage Response and Transcriptional Silencing* , 2010, The Journal of Biological Chemistry.

[21]  M. O’Connor,et al.  ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors , 2010, Molecular Cancer Therapeutics.

[22]  M. Kupiec,et al.  Proteasome Nuclear Activity Affects Chromosome Stability by Controlling the Turnover of Mms22, a Protein Important for DNA Repair , 2010, PLoS genetics.

[23]  Gary D Bader,et al.  The Genetic Landscape of a Cell , 2010, Science.

[24]  Gary D. Bader,et al.  DRYGIN: a database of quantitative genetic interaction networks in yeast , 2009, Nucleic Acids Res..

[25]  C. Myers,et al.  Synthetic genetic array (SGA) analysis in Saccharomyces cerevisiae and Schizosaccharomyces pombe. , 2010, Methods in enzymology.

[26]  P. Hieter,et al.  Synthetic lethal genetic interactions that decrease somatic cell proliferation in Caenorhabditis elegans identify the alternative RFC CTF18 as a candidate cancer drug target. , 2009, Molecular biology of the cell.

[27]  D. Drubin,et al.  A yeast killer toxin screen provides insights into a/b toxin entry, trafficking, and killing mechanisms. , 2009, Developmental cell.

[28]  Richard C. Jones,et al.  A key role for Ctf4 in coupling the MCM2‐7 helicase to DNA polymerase α within the eukaryotic replisome , 2009, The EMBO journal.

[29]  G. Giaever,et al.  Quantitative Phenotyping via Deep Barcode Sequencing , 2022 .

[30]  J. Hurwitz,et al.  Assembly of the Cdc45-Mcm2–7-GINS complex in human cells requires the Ctf4/And-1, RecQL4, and Mcm10 proteins , 2009, Proceedings of the National Academy of Sciences.

[31]  Michael J. Emanuele,et al.  A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene , 2009, Cell.

[32]  Sridhar Ramaswamy,et al.  Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells , 2009, Cell.

[33]  M. Stratton,et al.  The cancer genome , 2009, Nature.

[34]  P. Hieter,et al.  Specific synthetic lethal killing of RAD54B-deficient human colorectal cancer cells by FEN1 silencing , 2009, Proceedings of the National Academy of Sciences.

[35]  Michel Roberge,et al.  Screening for chemical inhibitors of heterologous proteins expressed in yeast using a simple growth-restoration assay. , 2009, Methods in molecular biology.

[36]  Sean R. Collins,et al.  A comprehensive strategy enabling high-resolution functional analysis of the yeast genome , 2008, Nature Methods.

[37]  Kathryn A. O’Donnell,et al.  Toward a comprehensive temperature-sensitive mutant repository of the essential genes of Saccharomyces cerevisiae. , 2008, Molecular cell.

[38]  Robert P. St.Onge,et al.  The Chemical Genomic Portrait of Yeast: Uncovering a Phenotype for All Genes , 2008, Science.

[39]  G. Parmigiani,et al.  Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers , 2008, Proceedings of the National Academy of Sciences.

[40]  Jean Gautier,et al.  A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. , 2008, Nature chemical biology.

[41]  Eun Mi Kim,et al.  DNA Damage Activates the SAC in an ATM/ATR-Dependent Manner, Independently of the Kinetochore , 2008, PLoS genetics.

[42]  Anindya Dutta,et al.  Mcm10 and And-1/CTF4 recruit DNA polymerase α to chromatin for initiation of DNA replication , 2007 .

[43]  Grant W. Brown,et al.  Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map , 2007, Nature.

[44]  F. Spencer,et al.  Systematic genome instability screens in yeast and their potential relevance to cancer , 2007, Proceedings of the National Academy of Sciences.

[45]  Anindya Dutta,et al.  Mcm10 and And-1/CTF4 recruit DNA polymerase alpha to chromatin for initiation of DNA replication. , 2007, Genes & development.

[46]  B. Weaver,et al.  Does aneuploidy cause cancer? , 2006, Current opinion in cell biology.

[47]  Inmar E. Givoni,et al.  Exploring the Mode-of-Action of Bioactive Compounds by Chemical-Genetic Profiling in Yeast , 2006, Cell.

[48]  W. Kaelin.  The Concept of Synthetic Lethality in the Context of Anticancer Therapy , 2005, Nature Reviews Cancer.

[49]  Thomas Helleday,et al.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase , 2005, Nature.

[50]  Alan Ashworth,et al.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.

[51]  J. Ptak,et al.  Three classes of genes mutated in colorectal cancers with chromosomal instability. , 2004, Cancer research.

[52]  V. Zakian,et al.  Saccharomyces cerevisiae Rrm3p DNA Helicase Promotes Genome Integrity by Preventing Replication Fork Stalling: Viability of rrm3 Cells Requires the Intra-S-Phase Checkpoint and Fork Restart Activities , 2004, Molecular and Cellular Biology.

[53]  Carlo Rago,et al.  Inactivation of hCDC4 can cause chromosomal instability , 2004, Nature.

[54]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[55]  Gary D Bader,et al.  Global Mapping of the Yeast Genetic Interaction Network , 2004, Science.

[56]  Michael I. Jordan,et al.  Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[57]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[58]  Ronald W. Davis,et al.  Functional profiling of the Saccharomyces cerevisiae genome , 2002, Nature.

[59]  Tyson A. Clark,et al.  Removal of a Single α-Tubulin Gene Intron Suppresses Cell Cycle Arrest Phenotypes of Splicing Factor Mutations in Saccharomyces cerevisiae , 2002, Molecular and Cellular Biology.

[60]  Gary D Bader,et al.  Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants , 2001, Science.

[61]  A. Murray,et al.  Genes involved in sister chromatid separation and segregation in the budding yeast Saccharomyces cerevisiae. , 2001, Genetics.

[62]  L. Hartwell,et al.  Integrating genetic approaches into the discovery of anticancer drugs. , 1997, Science.

[63]  K. Nasmyth,et al.  Cohesins: Chromosomal Proteins that Prevent Premature Separation of Sister Chromatids , 1997, Cell.

[64]  F. Spencer,et al.  Mitotic chromosome transmission fidelity mutants in Saccharomyces cerevisiae. , 1990, Genetics.